DexCom, Inc. (LON:0A4M)

London flag London · Delayed Price · Currency is GBP · Price in USD
81.67
0.00 (0.00%)
At close: Aug 21, 2025
Market Cap21.79B
Revenue (ttm)3.14B
Net Income (ttm)417.14M
Shares Outn/a
EPS (ttm)1.04
PE Ratio52.25
Forward PE31.33
Dividendn/a
Ex-Dividend Daten/a
Volume98,210
Average Volume6,735
Open81.67
Previous Closen/a
Day's Range81.67 - 81.67
52-Week Range64.90 - 90.77
Betan/a
RSI52.05
Earnings DateOct 23, 2025

About DexCom

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 1999
Employees 10,300
Stock Exchange London Stock Exchange
Ticker Symbol 0A4M
Full Company Profile

Financial Performance

In 2024, DexCom's revenue was $4.03 billion, an increase of 11.34% compared to the previous year's $3.62 billion. Earnings were $576.20 million, an increase of 6.41%.

Financial numbers in USD Financial Statements

News

There is no news available yet.